Headline: Singapore Upgrades 2025 Growth Outlook After Q3 Beats Expectations
Key Takeaways
Singapore’s economy accelerated more than expected in the third quarter, setting the stage for a stronger year ahead. Robust external demand and firmer activity among key trading partners prompted the government to sharply lift its 2025 growth outlook, even as it flagged a cooler patch beyond next year.
Gross domestic product expanded 4.2% year-on-year in Q3, outpacing a 4.0% market consensus and well above the 2.9% advance estimate. On a seasonally adjusted basis, the economy grew 2.4% quarter-on-quarter. Reflecting the improved momentum, the Ministry of Trade and Industry now expects GDP to grow around 4.0% in 2025, upgraded from the earlier 1.5%–2.5% range.
Officials cautioned that the upswing may moderate in 2026 as the global cycle cools. The growth projection for 2026 stands at 1.0%–3.0%, with manufacturing and trade-related services likely to expand at a slower pace. Enterprise Singapore forecast non-oil domestic exports to rise about 2.5% in 2025, before easing to 0.0%–2.0% growth in 2026.
Monetary settings remain steady. The Monetary Authority of Singapore left policy unchanged in October, citing resilient growth amid trade headwinds. While Singapore faces a 10% U.S. tariff on its exports—lower than rates applied to some regional peers—sector-specific risks persist, including a potential 100% levy on branded pharmaceuticals. Authorities have delayed implementation of the drug tariff to allow more time for negotiations.
Key Points: – Q3 GDP rose 4.2% year-on-year, beating expectations; quarter-on-quarter growth was 2.4% seasonally adjusted. – MTI raised the 2025 GDP forecast to around 4.0%, up from 1.5%–2.5%. – 2026 growth is projected at 1.0%–3.0%, with a softer outlook for manufacturing and trade-related services. – Enterprise Singapore sees NODX up about 2.5% in 2025; 2026 NODX growth forecast at 0.0%–2.0%. – MAS kept monetary policy unchanged in October amid resilient activity. – U.S. tariffs remain a risk, including a potential 100% tariff on branded pharmaceuticals; implementation has been delayed for talks.
Context
Current positioning around Altcoin News remains sensitive to primary-source updates, policy interpretation, and execution risk across major venues.
What To Watch
Key confirmation signals include sustained spot demand, funding stability, and whether price can hold reclaimed levels after headline-driven volatility.
If momentum weakens, traders will likely prioritize downside liquidity zones and risk-control positioning before adding new directional exposure.
Related: More from Altcoin News | ETH, SOL, XRP Surge 10%, Recovering War Losses in Altcoin | Wallet Hack Ends Solana DeFi Aggregator Step Finance in Altcoin
